Phase I study of peptides derived from novel cancer antigen using with Gemcitabine for advanced pancreatic cancer
Phase 1
- Conditions
- advanced pancreatic cancer
- Registration Number
- JPRN-UMIN000007504
- Lead Sponsor
- YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE Department of Digestive Surgery and Surgical Oncology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 18
Inclusion Criteria
Not provided
Exclusion Criteria
1. pregnant woman 2. 3. 4. 5. Steroid or immunosuppressive therapy 6. 7. 8.Doctors opinion
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method